Cue Biopharma, Inc.·4

Aug 16, 4:07 PM ET

PASSERI DANIEL R 4

4 · Cue Biopharma, Inc. · Filed Aug 16, 2023

Insider Transaction Report

Form 4
Period: 2023-08-14
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Purchase

    Common Stock

    2023-08-14$2.86/sh+3,000$8,580134,578 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION